1. Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab. (July 2018) Authors: Meredith, Ruby F.; Torgue, Julien J.; Rozgaja, Tania A.; Banaga, Eileen P.; Bunch, Patty W.; Alvarez, Ronald D.; Straughn, J. Michael; Dobelbower, Michael C.; Lowy, Andrew M. Journal: American journal of clinical oncology Issue: Volume 41:Number 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗